Found 45 matching trials
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer PHASE1 Purpose of this study is to determine appropriate dosing of ABI-009 and eva...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy PHASE3 This is a Phase 3, open-label single-arm trial designed to evaluate the saf...
Show More Location
Multiple Locations
Learn More & Join Trial
Intravesical BCG vs GEMDOCE in NMIBC PHASE3 The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer PHASE2 To our knowledge, there are no comparative studies on bacillus Calmette-Gue...
Show More Location
A.O.U. San Giovanni Battista Molinette
Learn More & Join Trial
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer PHASE2 This is an open-label, phase 2, randomized study of intravesical N-803 plus...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer PHASE2 The use of a designed viral vector that can destroy cancer cells while leav...
Show More Learn More & Join Trial
Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC PHASE2 The goal of this clinical trial is to learn whether a combination of two ch...
Show More Location
University of Iowa
Learn More & Join Trial
Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC PHASE3 This is a multicenter, randomized, open-label phase III study to determine ...
Show More Location
Peking University First Hospital
Learn More & Join Trial
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment PHASE1 The purpose of this study is to test the safety of the study drug 2141-V11 ...
Show More Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial